Bank Of New York Mellon Corp Lyra Therapeutics, Inc. Transaction History

Bank Of New York Mellon Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$4.95 - $6.6 $96,505 - $128,673	19,496 New	19,496 $98,000
Q1 2021 May 13, 2021	SELL	$10.38 - $15.61 $45,817 - $68,902	-4,414 Reduced 22.69%	15,036 $174,000
Q4 2020 Feb 09, 2021	BUY	$9.28 - $13.88 $35,328 - $52,841	3,807 Added 24.34%	19,450 $221,000
Q3 2020 Nov 12, 2020	BUY	$10.61 - $13.96 $25,410 - $33,434	2,395 Added 18.08%	15,643 $174,000
Q2 2020 Aug 12, 2020	BUY	$10.91 - $18.56 $144,535 - $245,882	13,248 New	13,248 $150,000

32.2M

21.1K

400

Ticker LYRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,826,400
Market Cap $5.73M
Description
Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.